This pro-tumor stromal configuration, aside from its close association with cancer cells, promotes an immunosuppressive TME by releasing inhibitory signals, particularly PVR, which engages with TIGIT on immune cells and suppresses their functions. The gene discussed is TIGIT; the disease is cancer.